About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Michigan | 904 Studies

Clinical Trials Breast CancerMichigan

Breast Cancer Clinical Trials in Michigan

Find 904 clinical trials for breast cancer near Michigan. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 121-140 of 904 trials

CompletedA Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic CancersThis Phase 1b/2a study will assess the efficacy, safety, and pharmacodynamics of CyPep-1 when administered directly into measurable tumor lesions in combination with the anti-PD-1…NCT05383170·Birmingham, Alabama and 24 others CompletedA Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma.NCT02614794·Birmingham, Alabama and 175 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerThe reason for this study is to see if the CD73 inhibitor LY3475070 alone or in combination with pembrolizumab is safe and effective in participants with advanced cancer.NCT04148937·Denver, Colorado and 11 others

UnknownCryoablation Therapy in Treating Patients With Invasive Ductal Breast CancerThis phase II trial is studying how well cryoablation therapy works in treating patients with invasive ductal breast cancer. Cryoablation kills tumor cells by freezing them.NCT00723294·Burbank, California and 15 others

CompletedTrastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabThe goal in this Phase 1 dose-escalation trial of the anti-IL-6R monoclonal antibody tocilizumab in combination with trastuzumab and pertuzumab in subjects with metastatic HER2…NCT03135171·Chicago, Illinois and 2 others

Active not recruitingPhase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)The study is intended to show superiority of AZD9833 in combination with CDK4/6 inhibitor (palbociclib, abemaciclib or ribociclib) versus aromatase inhibitors (anastrozole or…NCT04964934·Phoenix, Arizona and 263 others

RecruitingA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations.NCT06760819·Birmingham, Alabama and 53 others

CompletedHome-Based Symptom Management Via Reflexology for Breast Cancer PatientsThe purpose of this project is to test foot reflexology delivered by a friend or family member in the home for women with breast cancer.NCT01582971·Chicago, Illinois and 8 others

CompletedS9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerRATIONALE: Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer.NCT00031772·Birmingham, Alabama and 108 others

CompletedA Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast CancerRadiotherapy has been shown to reduce breast-cancer specific mortality in patients at high risk for distant dissemination.NCT00581256·Ann Arbor, Michigan

TerminatedRegistrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology TreatmentThis is a non-significant risk, double-blinded, randomized, registrational study to compare the effectiveness of two digital, software only, medical devices (SaMD) (attune™ and…NCT04862195·Glendale, California and 12 others

TerminatedRO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryThis phase I trial studies the side effects and best dose of RO4929097 (gamma-secretase/Notch signalling pathway inhibitor RO4929097) when given together with vismodegib in…NCT01071564·Baltimore, Maryland and 2 others

RecruitingA First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerThis is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.NCT06638307·Springdale, Arkansas and 46 others

CompletedChemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2Randomized phase II trial to study the effectiveness of chemotherapy with paclitaxel and the monoclonal antibody trastuzumab followed by chemotherapy in treating women who have…NCT00003992·Palo Alto, California and 44 others

CompletedPilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast RadiotherapyPatients with breast cancer receive low doses to smaller volumes of the heart, but they also have an excellent long-term survival, so it is crucial to study the effects of low…NCT02494453·Ann Arbor, Michigan

TerminatedMM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsThis study is an open label, randomized, multicenter trial of MM-302 plus trastuzumab.NCT02213744·Glendale, Arizona and 108 others

SuspendedEribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerThis randomized phase III trial studies how well eribulin mesylate or paclitaxel work as first- or second-line therapy in treating patients with stage IIIC-IV breast cancer that…NCT02037529·Scottsdale, Arizona and 38 others

RecruitingBGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsThis is a dose escalation and dose expansion study to compare how well BGB-43395, a selective cyclin-dependent kinase 4 (CDK4) inhibitor, works as monotherapy or in combination…NCT06120283·Denver, Colorado and 60 others

Active not recruitingA Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)The study will evaluate the safety and efficacy of datopotamab deruxtecan (also known as Dato-DXd, DS-1062a), when compared with Investigator's choice of standard of care…NCT05104866·Duarte, California and 166 others

CompletedA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic MalignanciesThe purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01949 when given in combination with immune therapies in participants with advanced or…NCT03241173·Birmingham, Alabama and 14 others

PreviousPage 7 of 46Next

Other Conditions in Michigan

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma